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Melanoma Molecular Subtypes: 
Unifying and Paradoxical Results
Nancy E. Thomas1, Peter A. Kanetsky2, Colin B. Begg3, Kathleen Conway4 
and Marianne Berwick5
In this issue, Hacker and colleagues provide further evidence that molecular sub-
types of malignant melanoma may develop along divergent pathways. The authors 
did not find an association between somatic BRAF-mutant melanoma and germline 
melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in 
light of previous studies demonstrating strong associations.
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Introduction
In this issue, Hacker et al. contribute 
new data indicating how BRAF-mutant 
melanomas can be included in their 
previously proposed divergent pathway 
model for melanoma development. Their 
findings lend support to BRAF-mutant 
melanomas developing along a pathway 
positively associated with young age at 
diagnosis, high nevus counts, contigu-
ous nevus remnants, and ability to tan, 
and inversely associated with evidence 
of high level of lifetime cumulative 
sun exposure. However, the authors 
found no association between germline 
melanocortin-1 receptor (MC1R) status 
and BRAF-mutant melanomas in an 
Australian population-based study. These 
results differ from two earlier publica-
tions (Fargnoli et al., 2008; Landi et al., 
2006) that reported strong associations 
in three independent populations (two 
from Italy and one from San Francisco).
Divergent pathways
The results of Hacker et al. (2010, this 
issue) are concordant with many other 
studies that have demonstrated dis-
tinct risk factors for melanomas harbor-
ing BRAF mutations. Both hospital and 
population-based studies on different 
continents have found BRAF mutations to 
be associated with young age at diagno-
sis (Edlundh-Rose et al., 2006; Liu et al., 
2007; Thomas et al., 2007). Others have 
reported that BRAF-melanomas were 
associated with contiguous nevus rem-
nants on histologic sections (Edlundh-
Rose et al., 2006; Poynter et al., 2006). 
Similar to the findings of Hacker et al. 
(2010), BRAF-mutant melanomas have 
been reported to be associated with high 
back nevus counts and increased ability to 
tan in a North Carolina population-based 
study (Thomas et al., 2007). Other studies 
have found BRAF-mutant melanomas to 
be inversely associated with chronically 
exposed anatomic site and solar elastosis, 
providing further evidence of an inverse 
association with high levels of cumulative 
sun exposure (Curtin et al., 2005).
Paradox and possible explanations
Hacker et al. (2010) report no association 
between germline MC1R variants and 
BRAF-mutant melanomas in 123 cases 
from Australia. Similarly, we examined 
the relationship between MC1R status 
and BRAF-mutant melanomas in our 
North Carolina population-based study, 
and, like those of Hacker and colleagues, 
our results do not support a strong asso-
ciation (unpublished data). In contrast, 
Landi et al. (2006) scored independent 
sets of 86 and 112 melanoma specimens 
from a case–control study in Italy and a 
hospital-based series in San Francisco 
for histologic evidence of chronic sun 
damage (CSD). The majority, 56 and 
58, respectively, did not show CSD. 
They reported that MC1R variants were 
strongly associated with BRAF-mutant 
melanomas in biopsies with little histo-
logic evidence of chronic sun damage 
(non-CSD) (Landi et al., 2006). More 
recently, in a separate case–control study 
in Italy that included 92 melanomas 
typed for BRAF mutations, Fargnoli et al. 
(2008) also reported germline MC1R vari-
ants to be strongly associated with BRAF-
mutations, independent of CSD status.
There are several possible explana-
tions for the different results among these 
studies. First, dissimilar estimates may be 
due, in part, to unique effects of specific 
MC1R variants, the frequencies of which 
differ somewhat among study popula-
tions. Second, there may be unidentified 
genotypic variation among populations 
that affects the association of MC1R 
variants with BRAF-mutant melanoma. 
For example, inherited variants in other 
genes related to pigmentation, tanning 
response, or nevus propensity might 
influence this association. Furthermore, 
environmental differences, in particular 
ambient sun exposure, could affect the 
relationship.
Gene–environment and gene–gene 
interactions involving MC1R could be 
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pigmentation might be expected to 
have less influence on eumelanin pro-
duction in these individuals.
Increased statistical power, along 
with ample representation of different 
populations, including those with dif-
ferent European ancestries, should help 
to solve this problem. This work could 
be approached through larger studies 
or meta-analyses including diverse 
populations. Genome-wide associa-
tion and candidate pathway studies to 
identify and assess additional inherited 
melanoma risk factors should provide 
complementary information. Genotypic 
variants may be found that are associ-
ated with BRAF-mutations or that modify 
the relationship between MC1R vari-
ants and BRAF mutations in melanoma. 
Candidate pathways of interest include 
those that affect pigment phenotype, 
tanning response, nevus propensity, and 
DNA damage response. An increased 
ability to assign inherited differences and 
somatic alterations in melanoma to path-
ways in the divergent pathway model of 
melanoma development should improve 
our understanding of melanoma risk and 
may lead to better risk prediction and 
targeted prevention.
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frequently harbor BRAF mutations. In 
addition, patients with albinism, who have 
melanocytes but who do not produce 
eumelanin, are at low risk of developing 
melanoma (Ihn et al., 1993). Furthermore, 
MC1R enhances repair of DNA photo-
products independent of pigmentation 
(Abdel-Malek et al., 2008), and MC1R 
variants increase the risk of melanoma 
even in individuals with darker complex-
ions, a characteristic that otherwise would 
be considered protective (Kennedy et al., 
2001; Palmer et al., 2000).
Because all studies to date examining 
the association of MC1R variants with 
BRAF-mutant melanoma are relatively 
small, we cannot rule out the possibility 
that the differences in results are attrib-
utable to chance alone and that further 
investigation with larger populations 
will clarify the relationship. In addi-
tion, few MC1R “R/R” participants have 
been represented in studies to date, 
making it difficult to assess the odds of 
BRAF-mutant melanoma in individuals 
who would be likely to have very low 
eumelanin levels and simultaneously 
decreased DNA damage responses 
due to their MC1R status. Other genes 
that regulate tanning responses or 
quite complex because MC1R functional 
status alone might have opposing effects 
on the risk of BRAF-mutant melanoma, 
as shown in Figure 1. In this model, we 
assume that basal pheomelanin produc-
tion is the null phenotype of MC1R and 
that epidermal pheomelanin levels do not 
vary among the groups based on findings 
that MC1R mutations reduce eumelanin 
but do not change pheomelanin con-
centration in mouse tail epidermis (Van 
Raamsdonk et al., 2009). Inheritance of 
decreased-function MC1R variants might 
increase the risk of BRAF-mutant mela-
noma through diminished constitutive 
and facultative pigmentation, less effec-
tive DNA damage response mechanisms, 
and increased generation of hydrogen 
peroxide (Abdel-Malek et al., 2008). 
However, carriage of functional MC1R 
alleles might increase risk because 
eumelanin, as well as pheomelanin, can 
contribute to oxidative stress (Meyskens 
et al., 2004), and individuals with more 
eumelanin may increase their sun expo-
sure because of their relatively decreased 
sun sensitivity.
Because of these competing effects, it is 
possible that genotypes with an intermedi-
ate loss of MC1R function might produce 
a favorable host phenotype for produc-
tion of BRAF-mutant nevi and melanoma. 
A combination of some eumelanin and 
decreased DNA damage responses may be 
most conducive to increased risk of BRAF 
mutations. Concordant with this possibil-
ity is the finding that blue-eyed individu-
als with more than one strong MC1R red 
hair variant (“R/R”), as defined by Duffy et 
al. (2004), tend to have fewer nevi, which 
Figure 1.  Potential opposing effects of MC1R variant status upon risk of BRAF-mutant melanoma. 
Functional MC1R allows the production of the darker eumelanin pigment and the tanning response. 
Carriage of decrease-of-function MC1R variants may allow increased BRAF-mutated melanoma 
risk through decreased photoprotection by eumelanin and attenuation of DNA damage response 
mechanisms. In opposition, more functional MC1R alleles may increase risk through increased 
eumelanin, leading to more oxidative stress and increased sun exposure due to decreased sun sensitivity. 
|
Associations between 
MC1R variants  
and BRAF mutations 
may depend  
on other genes.
Increased risk
through decreased
UV protection 
from eumelanin
Increased risk
from more sun  
exposure due to
less sun sensitivity
Increased risk through
decreased MC1R
mediated DNA
damage response 
Increased risk due
to increased
oxidative stress
related to eumelanin
MC1R Status
Wild type
Partial loss
of function
More complete
loss of function
In
cr
ea
se
d 
ris
k
In
cr
ea
se
d 
ris
k Increased risk
Increased risk
commentary
14 Journal of Investigative Dermatology (2010), Volume 130 
nonpigmented swordtail (Xiphophorus 
hellerii) parents, when backcrossed to 
swordtails, produce hybrids with phe-
notypes that segregate in an apparently 
Mendelian fashion, consistent with a 
two-gene inheritance model. In 1952, 
Breider hypothesized that melanomas 
developed in the susceptible pigmented 
Xiphophorus backcross hybrids as the 
result of the loss of a regulatory locus 
that inhibited genes controlling pigmen-
tation, anticipating the oncogene–tumor 
suppressor gene concept by almost two 
decades. Classical genetic recombina-
tion mapping subsequently established 
that a sex-linked pigmentation determin-
ing locus (Mdl) and an autosomal regu-
latory locus (R) were indeed involved 
in determining BC1 hybrid phenotypes, 
including melanoma susceptibility.
In the late 1980s and early 1990s, 
Schartl and colleagues published 
work that associated an EGFR-related 
gene, Xmrk, with the sex-linked Mdl 
locus (then called Tu). The molecular 
cloning and characterization of 
this oncogenic melanoma receptor 
kinase revolutionized the study of the 
Xiphophorus melanoma model and 
strengthened the concept of Xmrk as 
a dominant oncogene in the model, 
with R playing the role of a recessive 
tumor suppressor. The true identity 
of R has proven elusive, because the 
cloned candidate for this susceptibility 
locus, a homolog of the CDKN2 family 
called CDKN2AB, does not behave as 
predicted for a recessive tumor suppres-
sor. However, a number of complexities 
are revealed by studying other hybrid 
crosses available in Xiphophorus, and 
it is possible that R may be playing the 
role of a modifier of Xmrk activity rather 
than a frank suppressor, at least within 
Xiphophorus interspecies hybrids (see 
Butler et al., 2007, for a discussion of 
this point). In any event, there is abun-
dant evidence that Xmrk can behave 
as a dominant oncogene, specifically 
overexpressed in pigmented tissue 
and driving oncogenesis. In this issue, 
Schartl and colleagues express Xmrk as 
a transgene in the pigmented tissues of 
a fish other than Xiphophorus, called 
medaka, and demonstrate conclu-
sively that this gene is a powerful and 
dominant oncogene driving melanoma 
formation (Figure 1). Of greater interest, 
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Xmrk in Medaka:  
A New Genetic Melanoma Model
E. Elizabeth Patton1 and Rodney S. Nairn2
Melanoma is the most lethal form of skin cancer, and its incidence is rising rapidly 
(Chin et al., 2006; Linos et al., 2009). Highly aggressive, metastatic melanoma is 
notoriously resistant to chemotherapy, and early detection is critical for surgical 
excision (Gray-Schopfer et al., 2007). A detailed knowledge of the cellular, 
molecular, and genetic events during melanoma progression is highly relevant to 
both diagnosis and the development of new therapies. Animal models, such as 
the one described in this issue by Schartl and colleagues, are important tools for 
identifying the genetic and environmental factors that contribute to melanoma 
development, as well as identifying and testing new therapeutic strategies.
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Xmrk, Xiphophorus, and  
melanoma genetics
Fish have long been used in biomedical 
research and are increasingly used as 
models of human disease. Fish can 
develop a wide range of cancers, includ-
ing neurofibromatosis, hematologi-
cal and liver cancers, and melanoma, 
among others (Bunton, 1996). The 
Xiphophorus hybrid melanoma was rec-
ognized in the 1920s as a genetically 
controlled tumor model and has been 
studied since then (Meierjohann and 
Schartl, 2006). In this melanoma model, 
interspecies hybrids between pigmented 
platyfish (Xiphophorus maculatus) and 
